Goal: Our newsletter aims at providing regular updates on the science and the truth behind the current pandemic. We are dedicated to bringing the real science to the table and how the truth invalidates the current narrative, for which scientific evidence is now increasingly lacking. We’ll provide an update on a bi-weekly basis (on Mondays and Thursdays). We sincerely hope this Newsletter will contribute to raising people’s awareness about the consequences of human intervention in this pandemic, particularly of mass vaccination, from both an individual and public health perspective.
It's clear that the detrimental effect of mass vaccination will soon become obvious to an extent where even the most stubborn megalomaniac will have to acknowledge that he/she doesn't know where to hide for shame and blame.
And this is just the start. We’ll soon even provide evidence that the residual efficiency of vaccines against transmission (40 % according to analysis from WHO!) is NOT due to the vaccine but due to trained immunity. This is particularly the case in countries with less aggressive mas vax campaigns (several individuals got an opportunity to ‘train’ their innate immunity prior to receiving the vaccine!).
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.